Literature DB >> 22500514

Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility.

Xiaohui Zhang1, Hua Guo, Jindong Xu, Yun Li, Lisheng Li, Xiaoli Zhang, Xiaofeng Li, Ruifang Fan, Yue Zhang, Zhongping Duan, Jinxia Zhu.   

Abstract

The motility of distal colon could be inhibited by dopamine (DA), yet, the involved receptor is controversial according to the published reports. The goal of present study was to investigate DA receptor(s) mediated inhibition of DA on the colonic motility in rat. The contraction of isolated colon strips was assessed through isometric force transducer. The expressions of DA receptors in distal colon were detected through immunofluorescence and Western blot. DA concentration in colonic smooth muscle was measured by liquid chromatography/mass spectrometry. The results showed that DA inhibited the spontaneous motility of distal colon in a dose-dependent manner with EC50 8.3 μM. Tetrodotoxin increased colonic contractive frequency, but failed to affect the inhibition of DA on the colonic motility. Pretreatment with SCH-23390, an antagonist of dopaminergic receptor D1, shifted the dose-response curve to the right with EC50 of DA 37 μM. However, blocking dopaminergic receptor D2 with sulpiride, had no effect. The immunoreactivity of D1 and D2 were detected in the distal colon including myenteric plexus and smooth muscle. Acute cold-restraint stress (CRS) enhanced spontaneous contraction of rat distal colon, which was more sensitive to DA compared with control. Moreover, DA content and D1 expression in smooth muscle layer were increased under CRS condition. In conclusion, D1 in the smooth muscle is mediated DA inhibition on the spontaneous contraction of rat distal colon. The increased DA content and D1 receptor expression in the smooth muscle layer could be a compensatory effect under CRS condition to balance the enhanced colonic motility.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22500514     DOI: 10.1016/j.trsl.2012.01.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  9 in total

1.  Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells.

Authors:  Jiao-Jiao Xu; Si-Yuan Wang; Ye Chen; Guang-Ping Chen; Zai-Quan Li; Xue-Yan Shao; Liang Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

2.  Chronic constipation: improved understanding offers a new therapeutic approach.

Authors:  Gareth J Sanger
Journal:  J Physiol       Date:  2016-08-01       Impact factor: 5.182

3.  Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors.

Authors:  Michelangelo Auteri; Maria Grazia Zizzo; Antonella Amato; Rosa Serio
Journal:  J Physiol Biochem       Date:  2017-06-09       Impact factor: 4.158

4.  Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.

Authors:  Kiyotada Naitou; Hiroyuki Nakamori; Takahiko Shiina; Azusa Ikeda; Yuuta Nozue; Yuuki Sano; Takuya Yokoyama; Yoshio Yamamoto; Akihiro Yamada; Nozomi Akimoto; Hidemasa Furue; Yasutake Shimizu
Journal:  J Physiol       Date:  2016-04-28       Impact factor: 5.182

Review 5.  Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Authors:  Vinod Metta; Valentina Leta; Kandadai Rukmini Mrudula; L K Prashanth; Vinay Goyal; Rupam Borgohain; Guy Chung-Faye; K Ray Chaudhuri
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

Review 6.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

7.  Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.

Authors:  Martina Barrenschee; Dimitri Zorenkov; Martina Böttner; Christina Lange; François Cossais; Amelie Bernadette Scharf; Günther Deuschl; Susanne A Schneider; Mark Ellrichmann; Annette Fritscher-Ravens; Thilo Wedel
Journal:  Acta Neuropathol Commun       Date:  2017-01-05       Impact factor: 7.801

Review 8.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

9.  Enhanced Contractive Tension and Upregulated Muscarinic Receptor 2/3 in Colorectum Contribute to Constipation in 6-Hydroxydopamine-Induced Parkinson's Disease Rats.

Authors:  Xiao-Li Zhang; Xiao-Hui Zhang; Xiao Yu; Li-Fei Zheng; Xiao-Yan Feng; Chen-Zhe Liu; Zhu-Sheng Quan; Yue Zhang; Jin-Xia Zhu
Journal:  Front Aging Neurosci       Date:  2021-12-23       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.